Polaris Partners

Last updated
Polaris Partners
Company type Private ownership
Industry Venture Capital
Founded1996
Headquarters Boston, Massachusetts, United States
Products Investments
AUM $5.0 billion [1]
Number of employees
35+ [2]
Website polarispartners.com

Polaris Partners is a venture capital firm active in the field of healthcare and biotechnology companies. The company has offices in Boston, Massachusetts, New York, NY and San Francisco, California. [3] [4]

Contents

History

Polaris Partners was founded in 1996 by Jon Flint, Terry McGuire, Steve Arnold. [5] [6] [7]

The firm has over $5 billion in committed capital and is now making investments through its tenth fund. [1] The current managing partners are Amy Schulman, and Brian Chee. [1] [8]

Polaris Partners also has two affiliate funds. Polaris Growth Fund targets investments in profitable, founder-owned technology companies and is led by managing partners Bryce Youngren and Dan Lombard. [9] [10] Polaris Innovation Fund focuses on the commercial and therapeutic potential of early-stage academic research and is led by managing partners Amy Schulman and Ellie McGuire. [11] [12] [13] [14]

See also

Related Research Articles

<span class="mw-page-title-main">Venture capital</span> Form of private-equity financing

Venture capital (VC) is a form of private equity financing provided by firms or funds to startup, early-stage, and emerging companies, that have been deemed to have high growth potential or that have demonstrated high growth in terms of number of employees, annual revenue, scale of operations, etc.. Venture capital firms or funds invest in these early-stage companies in exchange for equity, or an ownership stake. Venture capitalists take on the risk of financing start-ups in the hopes that some of the companies they support will become successful. Because startups face high uncertainty, VC investments have high rates of failure. Start-ups are usually based on an innovative technology or business model and they are often from high technology industries, such as information technology (IT), clean technology or biotechnology.

Sequoia Capital is an American venture capital firm headquartered in Menlo Park, California which specializes in seed stage, early stage, and growth stage investments in private companies across technology sectors. As of 2022, the firm had approximately US$85 billion in assets under management.

<span class="mw-page-title-main">Mayfield (company)</span> Venture capital firm

Mayfield, also known as Mayfield Fund, is a US-based venture capital firm that focuses on early-stage to growth-stage investments in enterprise and consumer technology companies. Founded in 1969 and based in Menlo Park, California, it is one of Silicon Valley's oldest venture capital firms.

<span class="mw-page-title-main">GTCR</span> American private equity firm

GTCR LLC is a Chicago, Illinois-based private equity firm focused on leveraged buyout, leveraged recapitalization, growth capital and rollup transactions. The firm principally invests in high-growth industries, including financial services & technology, healthcare, information services & technology, and growth business services.

Norwest Venture Partners (Norwest) is an American venture and growth equity investment firm. The firm targets early to late-stage venture and growth equity investments across several sectors, including cloud computing and information technology, Internet, SaaS, business and financial services, and healthcare. Headquartered in Menlo Park, California, Norwest has offices in San Francisco and subsidiaries in Mumbai, India and Tel Aviv, Israel. The firm has funded more than 700 companies since inception.

Burr, Egan, Deleage & Co. (BEDCO) was a venture capital firm which focused on investments in information technology, communications, and healthcare/biotechnology companies.

Arlington Capital Partners is a Washington, DC based private equity firm focusing on leveraged buyout and recapitalization investments in middle market companies. Started in 1999, the firm manages $7.0 billion of committed capital out of five investment funds.

Terry McGuire is a co-founder and general partner of Polaris Partners based in the Boston office. McGuire focuses on life sciences investments.

<span class="mw-page-title-main">Lux Capital</span> American venture capital firm

Lux Capital is a venture capital firm based in New York City. It was founded in 2000, and focuses on investments in emerging technologies.

Babak "Bobby" Yazdani is an Iranian-American entrepreneur and investor specializing in early-stage, private U.S.-based modern enterprise technology companies.

Jonathan A. Flint is a venture capitalist and entrepreneur who co-founded venture capital firms Polaris Partners and Polaris Founders Capital, as well as the companies Living Proof and Icelandic Provisions.

<span class="mw-page-title-main">Funding Societies</span>

Funding Societies is a Southeast Asian digital financing platform for small and medium-sized enterprises (SMEs), headquartered in Singapore. It was the first such platform in Singapore to engage an escrow agency to independently and safely manage investors’ funds. In Indonesia it is known as Modalku. Since its launch, it has disbursed more than US$2.6 billion in business financing to MSMEs through more than 5.1 million loan transactions.

<span class="mw-page-title-main">Pitango</span> Israeli venture capital fund

Pitango VC, established in 1993, is Israel's largest venture capital fund with over $2.8 billion under management. Pitango VC invests through three dedicated funds, Pitango First, Pitango HealthTech, and Pitango Growth. Pitango invests in startups around the world, in domains such as Vertical SaaS, Digital Health, Deep Tech, FinTech & InsureTech, Devops, Generative AI, Web3, and FoodTech.

<span class="mw-page-title-main">DCM Ventures</span>

DCM (also known as DCM Ventures) is a venture capital firm located in Silicon Valley, Tokyo and Beijing. DCM was one of the first venture capital firms to invest in the early-stage technology sector in China, beginning in 1999. It has increasingly shifted away from Chinese investments due to US sanctions against China.

YL Ventures is an American-Israeli venture capital firm that specializes in seed stage cybersecurity investments.

<span class="mw-page-title-main">Venture capital in Poland</span> Overview of venture capital in Poland

Venture capital in Poland is a segment of the private equity market that finances early-stage high-risk companies based in Poland, with the potential for fast growth. As of March 2019, there is a total of 130 active VC firms in Poland, including local offices of international VC firms, and VC firms with mainly Polish management teams. Between 2009–2019, these entities have invested locally in over 750 companies, which gives an average of around 9 companies per portfolio. The Polish venture market accounts for 3% of the entire European ecosystem of VC investments, mainly in the digital space.

<span class="mw-page-title-main">Left Lane Capital</span> American venture capital firm

Left Lane Capital is a global venture capital firm that invests in internet and technology companies with a consumer orientation. The firm is headquartered in Brooklyn, New York, with an office in London.

Amy Weinfeld Schulman is an American healthcare biotech venture capitalist, trained as a lawyer, who serves as a managing partner at Polaris Partners and a trained lawyer. She focuses on investing in healthcare companies and early-stage biotech start-ups. She also chairs the Board of Directors for Alnylam Pharmaceuticals and ByHeart, and represents Polaris as a director for Kallyope, Thirty Madison, QurAlis, and Larkspur. She also practiced as a lawyer.

Graphene Ventures is a venture capital firm that invested primarily in early-stage tech companies in enterprise software and consumer technology. The firm operates in Palo Alto, Toronto (Canada), São Paulo (Brazil), and Riyadh.

References

  1. 1 2 3 "Brian Chee". California Health Care Foundation. Retrieved 2022-09-08.
  2. Polaris Venture Website: Who We Are Archived 2008-12-18 at the Wayback Machine
  3. "Polaris Partners Portfolio".
  4. DeAngelis, Allison. "Polaris Partners plans new $400M fund for life sciences, tech".
  5. "Investors hope to collect big return from Exchange.com". www.bizjournals.com. Retrieved 2022-09-08.
  6. "Terrance G. McGuire". Dartmouth Engineering. Retrieved 2022-09-08.
  7. "Stephen D. Arnold". Edutopia. Retrieved 2022-09-08.
  8. "Polaris Team | Polaris Partners" . Retrieved 2024-06-07.
  9. FinSMEs (2022-07-31). "Amplifire Receives Strategic Investment from Polaris Growth Fund". FinSMEs. Retrieved 2022-09-08.
  10. "Bryce Youngren". Polaris Growth. Retrieved 2022-09-08.
  11. "Breaking into Biotech with Amy Schulman, Polaris Partners". HARVARD ALUMNI ENTREPRENEURS. 9 July 2020. Retrieved 2022-09-08.
  12. "Amy Schulman '89 - Yale Law School". law.yale.edu. Retrieved 2022-09-08.
  13. "Experts in Residence (XIRs)". Harvard Office of Technology Development. Retrieved 2022-09-08.
  14. Solutions, Inc, Dude. "Women, Money & Tech". calendar.buffalo.edu. Retrieved 2022-09-08.